In addition, survival analysis showed that CPEB3 was a protective molecule in 7 out of 33 analyzed malignancies and it was the only prognosis-related molecule in the CPEB family in HCC (Fig. 8b). This evidence concerns the gene CPEB3 and hepatocellular carcinoma.